In addition, SGP-1-1 stimulates the production of SOD and reduces the production of MDA by down-regulating the activation of TLR4/NF-κB p65 pathway to reduce oxidative stress caused by diabetic nephropathy (Gong et al., 2021). Here, TLR4 is linked to diabetic kidney disease.